Greg Guyer News Today

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript April 24, 2024 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]

BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $0.18 EPS, expectations were $0.44.

Operator: Hello and welcome to the BioMarin Pharmaceutical Third Quarter 2023 Conference Call. All lines have been placed on meet to prevent any background noise.

Operator: Welcome to the BioMarin Pharmaceuticals First Quarter Investor Update Call. Hosting the conference call today from BioMarin is Traci McCarty, Group Vice President, Investor Relations.

A biopharmaceutical company has opened the expansion of its manufacturing plant following a €38 million investment over 4 years.

25 April 2023 By Tom Collins tom@TheCork.ie Increases the Company’s Capacity to Supply Medicines Globally In recent days the global biopharmaceutical company BioMarin Pharmaceutical Inc. opened the expansion of its manufacturing plant at Shanbally, Co. Cork. The company has invested €38 million over four years to create a state-of-the-art aseptic production facility. The new facility…

BioMarin Pharmaceutical has opened the expansion of its manufacturing plant at Shanbally, Co. Cork: with the site now able to provide end-to-end manufacturing for a number of the company’s commercial products.

He company has invested €38 million over four years to create a state-of-the-art aseptic production facility that will manufacture, package and label ...

BioMarin invested the money over a four-year period in its Irish operations. Its Cork manufacturing plant is its largest outside of the US.

Operator: Welcome to the BioMarin Fourth Quarter Investor Update Call. Hosting the conference call today from BioMarin is Traci McCarty, Group Vice President of Investor Relations.